explore -WSS

explore

author：Wikipedia 2025-08-12 09:08:37 - browse：2869

Adam's take main illustration — Molly Ferguson/STAT

Cassava Sciences has long claimed its experimental drug, called simufilam, slows the cognitive decline of people with Alzheimer’s. On Friday, we learned how: The company recruited a large number of people into its clinical trial who don’t have Alzheimer’s.

People who almost certainly had Alzheimer’s were also included in the study, but in this group, a placebo outperformed Cassava’s drug.

The conclusion, of course, is obvious: Simufilam is inactive. It’s an inert compound no more effective than a placebo. Cassava’s assertion that simufilam is showing “disease-modifying activity” falls apart given its study was opened to people who should have been ineligible because they were misdiagnosed with Alzheimer’s. Whether that was done intentionally or unwittingly isn’t known, but it’s certainly troubling and makes the case for immediate, regulatory intervention even stronger.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： A strong 6.5

hotspot

explore

WSS

What drug price negotiations mean for Medicare Part D

Advances in CAR

How to fix cancer clinical trials' diversity problem

Listen: Biogen's potential pivot, & Illumina's next chapter

What American doctors can learn from their Israeli counterparts

Amazon on where the company's health care bets are headed next

entertainment

explore

explore

Activists slam private health insurers over coverage restrictions

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

Drug repurposing or repositioning? The language matters

A look at other Americans who have crossed into North Korea over the years

The high cost of giving birth even with insurance

Medicaid rebukes states for mistakenly disenrolling children

Sports medicine is finally prioritizing gender equality

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Continuity nursing helped my family in our darkest PICU moments

Biden administration sends mixed signals on US soldier who crossed into North Korea

hotspot

What we know about the American soldier detained in North Korea

Listen: Biogen's potential pivot, & Illumina's next chapter

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

NIH nominee Bertagnolli will get October confirmation hearing

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

explore

hotspot

explore

focus